UNH UnitedHealth Group Incorporated Common Stock (DE)
เกี่ยวกับ UnitedHealth Group Incorporated Common Stock (DE) ภาพรวมบริษัทจาก Wikipedia
UnitedHealth Group Incorporated is an American multinational for-profit company based in Eden Prairie, Minnesota, specializing in health insurance and health care services. Selling insurance products under UnitedHealthcare, and health care services under the Optum brand, it is the world's fourth-largest company by revenue and the largest health care company by revenue. The company is ranked fourth on the 2026 Fortune Global 500.
อ่านเพิ่มเติม
UnitedHealth Group Incorporated is an American multinational for-profit company based in Eden Prairie, Minnesota, specializing in health insurance and health care services. Selling insurance products under UnitedHealthcare, and health care services under the Optum brand, it is the world's fourth-largest company by revenue and the largest health care company by revenue. The company is ranked fourth on the 2026 Fortune Global 500.
UnitedHealth Group had a market capitalization of more than $400 billion as of year-end 2025. The company is the largest health insurer in the United States, insuring over 50 million people, and operates globally.
UnitedHealth Group has faced numerous investigations, lawsuits, and fines, including SEC enforcement for stock option backdating, Medicare over-billing, unfair claims practices, mental health treatment denials, and anticompetitive behavior.
History
1970s–1990s
UnitedHealth Group originated in late 1974, when Minnesota-based Charter Med Incorporated was founded by Richard Taylor Burke. It originally processed claims for doctors at the Hennepin County Medical Society. UnitedHealthcare Corporation was founded in 1977 to purchase Charter Med and create a network-based health plan for seniors. It became a publicly traded company in 1984 and changed its name to UnitedHealth Group in 1998.
In 1988, UnitedHealthcare started its first pharmacy benefit management, through its Diversified Pharmaceutical Services subsidiary. It managed pharmacy benefits delivered both through retail pharmacies and mail. The subsidiary was sold to SmithKline Beecham in 1994 for $2.3 billion.
In 1994, UnitedHealthcare acquired Ramsey-HMO, a Florida insurer. In 1995, the company acquired The MetraHealth Companies Inc. for $1.65 billion. MetraHealth was a privately held company formed by combining the group healthcare operations of The Travelers Companies and MetLife. In 1996, UnitedHealthcare acquired HealthWise of America, which operated HMOs in Arkansas, Maryland, Kentucky and Tennessee.
In 1998, the company was reorganized as the holding company for hitherto independent companies UnitedHealthcare, Ovations, Uniprise, Specialized Care Services, and Ingenix and rebranded as "UnitedHealth Group". Also in 1998, UnitedHealth Group acquired HealthPartners of Arizona, operator of Arizona's largest AHCCCS provider.
2000s
In 2001, EverCare, a UnitedHealth Group subsidiary, merged with LifeMark Health Plans In 2002, UnitedHealth Group acquired GeoAccess and Medicaid insurance company AmeriChoice. In 2003, UnitedHealth Group acquired Mid Atlantic Medical Services, an insurer serving Maryland, Washington D.C., Virginia, Delaware and West Virginia. Also in 2003, UnitedHealth Group acquired Golden Rule Financial, a provider of health savings accounts. On July 21, 2003, Exante Bank started operating in Salt Lake City, Utah, as a Utah state-chartered industrial loan corporation. It changed its name to OptumHealth Bank in 2008 and to Optum Bank in 2012.
In April 2004, UnitedHealth Group acquired Touchpoint Health Plan, a Wisconsin health plan. In July 2004, the company acquired Oxford Health Plans.
In December 2005, the company acquired PacifiCare Health Systems. It agreed to divest parts of PacifiCare's commercial health insurance business in Tucson, Arizona and Boulder, Colorado to satisfy antitrust regulator concerns, and also agreed to end its network access agreement with Blue Shield of California. The Tucson business was sold to Cigna. The company acquired Prescription Solutions, another pharmacy benefits manager, as part of its acquisition of PacifiCare Health Systems. This business was later rebranded OptumRx.
In February 2006, the company acquired John Deere Health Care. The same year, William W. McGuire stepped down as chairman and director due to his involvement in the employee stock options scandal. He was replaced by CEO Stephen Hemsley who had served as president and COO and a member of the board of directors. McGuire's exit compensation from UnitedHealth was anticipated to be $1.1 billion, but he only received $618 million after returning $420 million in stock options.
In February 2008, the company acquired Sierra Health Services for $2.6 billion. As part of the transaction, to obtain regulatory approval, 25,000 customers were sold to Humana. In July 2009, UnitedHealth Group agreed to acquire Health Net's Northeast licensed subsidiaries for up to $570 million in payments spread out over two years.
2010s
Through 2010 and into 2011, senior executives of the company met monthly with executives of other health insurers to limit the effect of the health care reform law. In July 2010, Ingenix acquired Picis Clinical Solutions, Inc., a health information provider for the high-acuity areas of hospitals. In 2011, Logistics Health, Inc. of La Crosse, Wisconsin, was acquired by OptumHealth. In September 2014, the office buildings where LHI is based were sold to UnitedHealth Group for $45 million. In February 2012, the company acquired XLHealth, a sponsor of Medicare Advantage health plans with a primary focus on medicare recipients with special needs such as those with chronic illness and those eligible for Medicaid ("dual eligibles"). In October 2012, UnitedHealth Group and Amil Participações, one of the biggest Brazilian health insurance companies, completed the first phase of their merger.
In February 2014, Optum secured a majority stake in the Washington, D.C.–based startup Audax Health. Audax's CEO, Grant Verstandig, continued running the firm alongside COO David Ko. In October 2014, Optum Health acquired the health services unit of Alere for $600 million cash.
In March 2015, it was announced that CatamaranRx would be acquired by OptumRx. In April 2016, the company announced it was pulling out of all but a "handful" of state healthcare exchanges provided under Affordable Care Act and will continue to sell only in three states in 2017.
In 2017, UnitedHealth's Optum unit acquired Rally Health, a company started by Audax Health's executives. Prior to acquisition, in 2015, UnitedHealth supported Rally Health as a majority investor, and through enrolling more than 5 million UnitedHealth policy holders in Rally Health's flagship product, Rally. The close relations between UnitedHealth, Audax Health and Rally Health follows a close personal relationship between Grant Verstandig (Audax and Rally) and UnitedHealth's President and CFO at the time, David Wichmann.
In June 2019, UnitedHealth's Optum division acquired DaVita Medical Group from DaVita, Inc. for $4.3 billion. That year, the company also agreed to acquire Equian for $3.2 billion. On June 19, 2019, UnitedHealth acquired the online patient community platform PatientsLikeMe for an undisclosed amount and it will be incorporated into UnitedHealth Group's research division.
In November 2019, Andrew Witty was named president of UnitedHealth Group, in addition to his role as chief executive of the company's Optum division.
2020s–present
UnitedHealth announced in March 2022 that it would acquire LHC Group for $5.4 billion. The deal will expand its home health capabilities by combining LHC's services with UnitedHealth's Optum unit.
In 2022, UnitedHealth Group said there would be no out-of-pocket costs for albuterol, epinephrine, glucagon, insulin, and naloxone for fully insured members starting in 2023. The discounts were guaranteed for less than a quarter of UnitedHealthcare's membership and did not extend to those enrolled in UHC's Medicare Advantage and Medicaid plans.
In 2023, UnitedHealthGroup announced it would move its headquarters from Minnetonka to Eden Prairie, Minnesota.
In February 2024, UnitedHealth Group completed the sale of its operations in Brazil.
In January 2021, UnitedHealth announced the acquisition of Change Healthcare, the largest health payments platform in the US, which the US Justice Department tried to block on antitrust grounds in February 2022; the sale went through by September. 18 months later, in February 2024, the subsidiary was brought completely down by the 2024 Change Healthcare ransomware attack, and the Justice Department announced that it was opening a new antitrust and Medicare overcharging probe. Despite making a ransomware payment, services remained down or incomplete for months. The CEO, Andrew Witty, was called before the US House and US Senate to testify about the cyberattack and DoJ concerns. In late April 2024, the Senate held a hearing concerning the cyberattack and UnitedHealth's response. Andrew Witty went before the Senate stating that there needed to be a strong digital security system in place along with an adequate backup plan. UnitedHealth revealed the hackers did gain access to patient information, but the Senate was informed the company is not yet aware of the extent of the data breach.
In June 2026, UnitedHealth Group announced plans to invest $3 billion in artificial intelligence in 2026 and 2027.
Killing of Brian Thompson
On December 4, 2024, Brian Thompson, the CEO of UnitedHealth Group's insurance subsidiary UnitedHealthcare, was killed in a shooting in New York City. The shooting occurred outside the New York Hilton Midtown, where UnitedHealth Group was hosting an investor event. Reactions to the shooting on social media were defined by resentment and criticism of UnitedHealthcare, the American health insurance system, and widespread disdain towards Thompson. Police later arrested a suspect, Luigi Mangione, and charged him with murder. Tim Noel joined UnitedHealthcare in 2007 and succeeded Brian Thompson as the CEO. Prior to becoming CEO, Noel was in charge of UnitedHealthcare's Medicare Advantage plans.
Further events
In November 2025, Scott Gottlieb, the former commissioner of the Food and Drug Administration, joined UnitedHealth Group's board of directors.
Organizational structure
UnitedHealth Group has about 2700 subsidiaries and affiliates worldwide, the highest profile being Optum and UnitedHealthcare.
Optum
Formed in 2011, Optum says that it provides "data and analytics, pharmacy care services, population health, healthcare delivery, and healthcare operations".
It is organized into three businesses:
OptumHealth – provides primary and secondary care.
OptumInsight – provides data analytics, technology, and operations services.
OptumRX – provides pharmacy services.
UnitedHealthcare
UnitedHealthcare (UHC) is an insurance and managed care company with three main divisions:
UnitedHealthcare Employer and Individual – provides health benefit plans and services for large national employers and individuals.
UnitedHealthcare Medicare and Retirement – provides health and well-being services to individuals age 65 and older.
UnitedHealthcare Community and State – serves state programs that care for the economically disadvantaged, the medically underserved, and people without the benefit of employer-funded health care coverage, in exchange for a monthly premium per member from the state program.
Finance
For the fiscal year 2022, UnitedHealth Group reported earnings of US$20.64 billion, with an annual revenue of US$324.16 billion. UnitedHealth Group's 2023 revenue grew by $47.5 billion, or 14.6%, on annualized revenue of $371.6 billion. Operating income for 2023 was $32.4 billion (up 13.8%). Cash flows from operations were $29.1 billion. UnitedHealth Group’s 2024 revenues grew $28.7 billion or 8% year-over-year to $400.3 billion. Earnings from operations of $32.3 billion compared to $32.4 billion in 2023. Cash flows from operations were $24.2 billion.
Lobbying and political activity
In 2009, according to OpenSecrets, people affiliated with UnitedHealth Group gave $4.77 million to political candidates and groups. The Affordable Care Act was being discussed in Congress at the time and was subsequently passed in the first quarter of 2010. In 2010 UnitedHealth Group hired nine different lobbying firms to work on its behalf. In addition, its corporate political action committee (PAC), called United for Health, spent an additional $1 million on lobbying activities. UnitedHealth Group subsequently spent $4.11 million to $4.75 million from 2011 to 2021.
The Lewin Group
The Lewin Group is a policy research and consulting firm that provides an economic analysis of health care and human services issues and policies. The organization has existed for about 40 years and has maintained a nonpartisan reputation through the many ownership changes that have occurred over that time. The Lewin Group was purchased in 2007 by Ingenix, a subsidiary of UnitedHealth Group, but alleges editorial and analytical "independence" from UnitedHealth Group, its parent company. The Lewin Group discloses its ownership in its reports and on its website. While the Lewin Group does not advocate for or against any legislation, both Democratic and Republican politicians frequently cite the firm's studies to argue for and against various U.S. healthcare reform proposals. For example, Democratic Senator Ron Wyden uses Lewin Group estimates to cite the feasibility of his Healthy Americans Act. Former U.S. Representative Eric Cantor, the former House Republican Whip, has referred to the organization as "the nonpartisan Lewin Group" in arguing against government-funded health insurance proposals.
Several Lewin studies have been used to argue both for and against the inclusion of a public option in national health reform. Lewin clients who often cite its findings include The Commonwealth Fund, which, in 2009, held up a Lewin study it commissioned to advocate for a public plan. The report showed that legislative proposals would achieve nearly universal coverage and "estimated that a public plan could offer small businesses insurance that is at least 9 percent cheaper than current small-business policies."
However, the Lewin Group has acknowledged that clients sometimes choose to keep the results of studies they have commissioned private. Indeed, Lewin Group Vice President John Sheils told The Washington Post that "sometimes studies come out that don't show exactly what the client wants to see. And in those instances, they have [the] option to bury the study."
Criticism and controversies
SEC investigation
In 2006, the U.S. Securities and Exchange Commission (SEC) began investigating the conduct of UnitedHealth Group's management and directors, for backdating of stock options. Investigations were also started by the Internal Revenue Service and prosecutors in the U.S. attorney's office for the Southern District of New York, who subpoenaed documents from the company. The investigations came to light after a series of probing stories in the Wall Street Journal in May 2006, discussing the apparent backdating of hundreds of millions of dollars' worth of stock options by UHC management. The backdating apparently occurred with the knowledge and approval of the directors, according to the Journal. Major shareholders have filed lawsuits accusing former New Jersey governor Thomas Kean and UHC's other directors of failing in their fiduciary duty. On October 15, 2006, CEO William W. McGuire was forced to resign, and relinquish hundreds of millions of dollars in stock options.
On December 6, 2007, the SEC announced a settlement under which McGuire was to repay $468 million, including a $7 million civil penalty, as a partial settlement of the backdating prosecution. He was also barred from serving as an officer or director of a public company for ten years. This was the first time in which the little-used "clawback" provision under the Sarbanes-Oxley Act was used against an individual by the SEC. The SEC continued its investigations even after it in 2008 settled legal actions against both UnitedHealth Group itself and its former general counsel.
American Chiropractic Association lawsuit
In June 2006, the American Chiropractic Association filed a national class-action lawsuit against the American Chiropractic Network (ACN), which is owned by UnitedHealth Group and administers chiropractic benefits, and against UnitedHealth Group itself, for alleged practices in violation of the federal Racketeer Influenced and Corrupt Organizations Act (RICO). The Missouri Department of Insurance, Financial Institutions and Professional Registration determined that UnitedHealth Group violated state insurance laws, so levied $536,000 in fines and ordered more than 50,000 cases re-opened; any improperly denied claims must have been reimbursed with interest for chiropractors and patients.
OptumInsight, a.k.a. Ingenix lawsuit
In February 2008, New York State Attorney General Andrew Cuomo announced an industry-wide investigation into a scheme by health insurers to defraud consumers by manipulating reasonable and customary rates. The announcement included a statement that Cuomo intended "to file suit against Ingenix, Inc., its parent UnitedHealth Group, and three additional subsidiaries." Cuomo asserted that his investigation found that rates found in a database of health care charges maintained by Ingenix were lower than what he determined was the actual cost of certain medical expenses. Cuomo said this inappropriately allowed health insurance companies to deny a portion of provider claims, thereby pushing costs down to members.
On January 13, 2009, Ingenix announced an agreement with the New York State attorney settling the probe into the independence of the health pricing database. Under the settlement, UnitedHealth Group and Ingenix would pay $50 million to finance a new, non-profit entity that would develop a new healthcare pricing database. Ingenix would discontinue its medical pricing databases when the new entity makes its product available. The company acknowledged the appearance of a conflict of interest but admitted no wrongdoing.
On January 15, 2009, UnitedHealth Group announced a $350 million settlement of three class action lawsuits filed in Federal court by the American Medical Association, UnitedHealth Group members, healthcare providers, and state medical societies for not paying out-of-network benefits. This settlement came two days after a similar settlement with Cuomo.
On October 27, 2009, Cuomo announced the creation of FAIR Health, an independent, non-profit organization that would develop a nationwide database for consumer reimbursement, as well as a website where consumers would be able to compare prices before choosing doctors. To fund FAIR Health, the Attorney General's office secured nearly $100 million from insurers such as Aetna, UnitedHealth Group, and Anthem Inc.
PacifiCare fine in California
In 2008, the California Department of Insurance took action against UnitedHealthcare's subsidiary PacifiCare Health Systems, acquired in 2005, ultimately fining UnitedHealthcare around $173 million for an estimated over 900,000 violations of the Unfair Insurance Practices Act; by 2019, the case was still being disputed in court, with the possibility of affirming $91 million in penalties.
Medicare overbilling lawsuit
A whistleblower lawsuit filed in 2011 charged UnitedHealth Group's data analytics division with assisting in defrauding Medicare by boosting risk adjustment scores from Medicare Advantage companies. The suit alleged that UnitedHealth Group subsidiary Ingenix (now OptumInsight) "defrauded the United States of hundreds of millions – and likely billions – of dollars." Former UnitedHealth executive Benjamin Poehling brought the suit under the False Claims Act. The government said it would proceed on claims against two healthcare companies, UnitedHealth and its Texas subsidiary WellMed Medical Management. In February 2017, a federal judge unsealed the suit after the Department of Justice announced it would join the case.
CMS fine over Medicare Part D
In 2017, the Centers for Medicare and Medicaid Services (CMS) fined UnitedHealthcare $2.5 million after discovering issues in Medicare Part D leading to delays or denials in a 2016 audit.
2018 New Jersey fine
In 2018, the New Jersey Department of Banking and Insurance fined UnitedHealthcare $2.5 million due to various compliance issues; this was the largest fine against a licensee in nine years.
Richard Cole, and others v. UnitedHealthcare
On April 29, 2019, Judge Robert N. Scola Jr. of the United States District Court for the Southern District of Florida, a cancer survivor, recused himself from a case against UnitedHealthcare, stating that the company's denial of treatment was "immoral and barbaric", and that his opinions regarding the company would prevent him from "deciding this case fairly and impartially."
Mental health treatment lawsuit
As reported by openminds.com:
On September 13, 2019, three addiction and mental health treatment centers sued United Behavioral Health (UBH), UnitedHealthcare's mental health subsidiary. The centers alleged that UBH wrongfully denied $5 million in behavioral health treatment claims for self-insured and fully insured employer health plans for residential and outpatient treatment from 2011 to 2017. The case involves claims for 157 employer group health plan members, including children.
Pennsylvania lawsuit
In 2019, UnitedHealthcare paid a $1 million penalty to settle Pennsylvania regulators' allegations that the company violated state and federal laws when paying medical claims, particularly for patients seeking treatment for autism and substance use disorders. The regulators also compelled the company to pay restitution for wrongly denied or delayed claims and to spend $800,000 on an outreach campaign to notify consumers of their mental health and substance use disorder benefits.
Dispute with TeamHealth
In late 2021, Tennessee-based physician network TeamHealth, a subsidiary of the private equity company Blackstone Inc., sued UnitedHealthcare in the 8th District Court of Clark County, Nevada, alleging the insurer underpaid claims to three of TeamHealth's Nevada-based affiliates. In November 2021, the jury unanimously found United guilty of "oppression, fraud, and malice" in its conduct and awarded TeamHealth $2.65 million in compensatory damages. In December, the jury reconvened to determine punitive damages and awarded TeamHealth $60 million. TeamHealth plans to pursue similar legal action against United and other insurers in New Jersey, Pennsylvania, New York, Florida, Oklahoma, and Texas.
Medicare Advantage overbilling
An October 2021 New York Times report identified UnitedHealth in a list of Medicare insurers accused of over-billing. According to the Inspector General, a whistleblower came forward, so the U.S. government went after UnitedHealth for over-billing Medicare. Executives at UnitedHealth Group told workers to mine old medical records for more illnesses, to identify diagnoses of serious diseases that might have never existed, inflating bills paid by the federal government's Medicare Advantage program.
A study by the Kaiser Family Foundation found that in 2021, Medicare Advantage programs provided insurers with double the gross margin of insurance for individuals, groups, or Medicaid Managed Care.
In July 2024, the Wall Street Journal concluded that UnitedHealth was the worst offender among private insurers who made dubious diagnoses in their clients in order to trigger large payments from the government's Medicare Advantage program. The patients often did not receive any treatment for those insurer-added diagnoses. The report, based on Medicare data obtained from the federal government under a research agreement, calculated that diagnoses added by UnitedHealth for diseases patients had never been treated for had yielded $8.7 billion in payments to the company in 2021 – over half of its net income of $17 billion for that year.
In July 2025, the Wall Street Journal reported that United States Department of Justice officials were interviewing former UnitedHealth employees in connection with the investigation, and later that month, UnitedHealth confirmed that it was under criminal and civil federal investigation for its Medicare practices. The company said it cooperated with those probes after reaching out to the DOJ.
Change Healthcare acquisition
In February 2022, the United States Department of Justice sued to stop UnitedHealth Group's $8 billion acquisition of Change Healthcare, arguing that the deal would give UnitedHealth access to its competitors' data and ultimately push up healthcare costs. The Justice Department said that UnitedHealth knew that access to claims would give it a view into rival health plans at Humana, Anthem Inc, CVS Health, Aetna, and Cigna. A U.S. judge rejected the department's bid in September. Following the completion of the acquisition in October 2022, the parties agreed that the appeal would be voluntarily dismissed, with no reasons provided by the Justice Department for dropping the appeal.
Insider trading lawsuit
In May 2024, the City of Hollywood Firefighters Pension Fund sued UnitedHealth Group for alleged insider trading, claiming that then-Board Chair and future chairman and CEO Stephen Hemsley and then-UnitedHealthcare CEO Brian Thompson had sold millions of dollars worth of shares in UHG since October 2023 with foreknowledge that the United States Department of Justice were investigating them.
Use of algorithmic AI model to deny claims
UnitedHealth Group has faced a lawsuit over its use of an algorithmic AI model created by naviHealth, which UnitedHealth acquired in 2020, to deny claims. The lawsuit alleged that the model, named nH Predict, had a 90% error rate. A spokesperson for UnitedHealth denied that they use the model to deny claims when questioned by The Guardian.
Secret payments to nursing homes
In May 2025, The Guardian published an investigative report which uncovered a systemic effort by UnitedHealth to secretly pay nursing homes bonuses to deny hospital transfers for nursing home residents who needed immediate hospital care. Other tactics uncovered by The Guardian include UnitedHealth managers pressuring nurse practitioners to persuade members to sign onto Do not resuscitate agreements and payments for leaking confidential patient data to UnitedHealth sales teams. In June, UnitedHealth sued The Guardian for defamation over the findings of their article.
Campaign against critics
In July 2025, a New York Times investigation revealed that UnitedHealth Group, with the help of the law firm Clare Locke, had made legal threats against journalists, social media users and healthcare professionals who criticized their policies and practices. UnitedHealth also made take-down requests to social media companies hosting content critical of them.
Foundations
Foundations affiliated with UnitedHealth Group include the UnitedHealth Foundation (UHF) and the UnitedHealthcare Children's Foundation (UHCCF), both of which were established in 1999.
UHF pledged $100 million over ten years to fund scholarships and workforce development programs focused on increasing ethnic and racial diversity within the health care industry. UHF's investment will support 10,000 physicians from underrepresented communities: 5,000 students with a primary care focus and 5,000 physicians who want to advance careers in mental health, nursing, midwifery and medicine. The work of this fund is part of a broader initiative in which UnitedHealth Group has teamed up with nine organizations to provide scholarships to more than 3,000 students through the Diverse Scholars Initiative.
UHCCF administers grants to help pay for medical costs for families with coverage gaps. According to UHCCF, the foundation raises money for medical grants by selling gift items such as backpacks, books, cards, and games, some of which are created by children.
แหล่งที่มา: Wikipedia (ภาษาอังกฤษ), CC BY-SA 4.0 · ดูบน Wikipedia ↗
UNH ภาพรวมหุ้น ราคา, มูลค่าหลักทรัพย์ตามราคาตลาด, P/E, EPS, ROE, อัตราส่วนหนี้สินต่อทุน, ช่วงราคา 52 สัปดาห์
UNH กราฟราคาหุ้น OHLCV รายวันพร้อมตัวชี้วัดทางเทคนิค — แพน ซูม และปรับแต่งมุมมองของคุณ
ผลการดำเนินงาน 10 ปี แนวโน้มรายได้ กำไรสุทธิ อัตรากำไร และ EPS
การประเมินมูลค่า อัตราส่วน P/E, P/S, P/B, EV/EBITDA — หุ้นมีราคาแพงหรือถูก?
ความสามารถในการทำกำไร อัตรากำไรขั้นต้น, อัตรากำไรจากการดำเนินงาน และอัตรากำไรสุทธิ; ROE, ROA, ROIC
สุขภาพทางการเงิน หนี้สิน, สภาพคล่อง, ความสามารถในการชำระหนี้ — ความแข็งแกร่งของงบดุล
การเติบโต การเติบโตของรายได้, EPS และกำไรสุทธิ: YoY, CAGR 3 ปี, CAGR 5 ปี
ประสิทธิภาพของเงินทุน อัตราหมุนเวียนสินทรัพย์, อัตราหมุนเวียนสินค้าคงคลัง, อัตราหมุนเวียนลูกหนี้
เงินปันผล ผลตอบแทน, อัตราการจ่ายเงินปันผล, ประวัติเงินปันผล, CAGR 5 ปี
| วันที่ไม่ได้รับสิทธิปันผล | จำนวน |
|---|---|
| 15 มิถุนายน 2026 | $2.3200 |
| 9 มีนาคม 2026 | $2.2100 |
| 8 ธันวาคม 2025 | $2.2100 |
| 15 กันยายน 2025 | $2.2100 |
| 16 มิถุนายน 2025 | $2.2100 |
| 10 มีนาคม 2025 | $2.1000 |
| 9 ธันวาคม 2024 | $2.1000 |
| 16 กันยายน 2024 | $2.1000 |
| 17 มิถุนายน 2024 | $2.1000 |
| 8 มีนาคม 2024 | $1.8800 |
| 1 ธันวาคม 2023 | $1.8800 |
| 8 กันยายน 2023 | $1.8800 |
| 15 มิถุนายน 2023 | $1.8800 |
| 10 มีนาคม 2023 | $1.6500 |
| 2 ธันวาคม 2022 | $1.6500 |
| 9 กันยายน 2022 | $1.6500 |
| 16 มิถุนายน 2022 | $1.6500 |
| 11 มีนาคม 2022 | $1.4500 |
| 3 ธันวาคม 2021 | $1.4500 |
| 10 กันยายน 2021 | $1.4500 |
UNH ความเห็นหลายต่อหลายของนักวิเคราะห์ มุมมองนักวิเคราะห์ทั้งเชิงบวกและเชิงลบ, ราคาเป้าหมาย 12 เดือน, อัพไซด์
- ซื้อแนะนำ 8 23.5%
- ซื้อ 19 55.9%
- ถือ 7 20.6%
- ขาย 0 0.0%
- ขายแนะนำ 0 0.0%
ราคาเป้าหมาย 12 เดือน
26 นักวิเคราะห์ · 2026-08-15ประวัติผลประกอบการ EPS จริงเทียบกับประมาณการ, เปอร์เซ็นต์ส่วนต่าง%, อัตราการชนะ, วันประกาศผลประกอบการครั้งถัดไป
| งวด | EPS Actual | EPS คาด | ส่วนต่าง |
|---|---|---|---|
| 30 มิถุนายน 2026 | $6.38 | $4.95 | 1.4% |
| 31 มีนาคม 2026 | $7.23 | $6.64 | 0.59% |
| 31 ธันวาคม 2025 | $2.11 | $2.12 | -0.01% |
| 30 กันยายน 2025 | $2.92 | $2.82 | 0.10% |
| 30 มิถุนายน 2025 | $4.08 | $4.53 | -0.45% |
| 31 มีนาคม 2025 | $7.20 | $7.36 | -0.16% |
การเปรียบเทียบกับบริษัทคู่เทียบ (อุตสาหกรรมย่อย GICS) เมตริกสำคัญเทียบกับบริษัทในกลุ่มอุตสาหกรรมเดียวกัน
| Ticker | มูลค่าตลาด | P/E | รายได้ YoY | อัตรากำไรสุทธิ | ROE | อัตรากำไรขั้นต้น |
|---|---|---|---|---|---|---|
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | — |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | — |
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | — |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | — |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| ALHC | $4.03B | — | 46.1% | -0.02% | -0.52% | — |
| CLOV | — | -5.1 | 40.3% | -4.5% | -26.2% | — |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
ปัจจัยพื้นฐานฉบับเต็ม ตัวชี้วัดทั้งหมดรายปี — งบกำไรขาดทุน, งบดุล, งบกระแสเงินสด
งบกำไรขาดทุน 14
| ตัวชี้วัด | แนวโน้ม | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $447.57B | $400.28B | $371.62B | $324.16B | $287.60B | $257.14B | $242.16B | $226.25B | $201.16B | $184.84B | $157.11B | $130.47B | |
| Cost of Revenue | $50.66B | $46.69B | $38.77B | $33.70B | $31.03B | $30.75B | $28.12B | $27.00B | $24.11B | $24.42B | $16.21B | $3.83B | |
| SG&A Expense | $59.59B | $53.01B | $54.63B | $47.78B | $42.58B | $41.70B | $35.19B | $34.07B | $29.56B | $28.40B | $24.31B | $21.26B | |
| Operating Expenses | $428.60B | $367.99B | $339.26B | $295.73B | $263.63B | $234.74B | $222.47B | $208.90B | $185.95B | $171.91B | $146.09B | $120.20B | |
| Operating Income | $18.96B | $32.29B | $32.36B | $28.43B | $23.97B | $22.41B | $19.68B | $17.34B | $15.21B | $12.93B | $11.02B | $10.27B | |
| Interest Expense | $4.00B | $3.91B | $3.25B | $2.09B | $1.66B | $1.66B | $1.70B | $1.40B | $1.19B | $1.07B | $790M | $618M | |
| Pretax Income | $14.70B | $20.07B | $29.11B | $26.34B | $22.31B | $20.74B | $17.98B | $15.94B | $14.02B | $11.86B | $10.23B | $9.66B | |
| Income Tax | $1.89B | $4.83B | $5.97B | $5.70B | $4.58B | $4.97B | $3.74B | $3.56B | $3.20B | $4.79B | $4.36B | $4.04B | |
| Net Income | $12.06B | $14.40B | $22.38B | $20.12B | $17.29B | $15.40B | $13.84B | $11.99B | $10.56B | $7.02B | $5.81B | $5.62B | |
| EPS (Basic) | $13.28 | $15.64 | $24.12 | $21.47 | $18.33 | $16.23 | $14.55 | $12.45 | $10.95 | $7.37 | $6.10 | $5.78 | |
| EPS (Diluted) | $13.23 | $15.51 | $23.86 | $21.18 | $18.08 | $16.03 | $14.33 | $12.19 | $10.72 | $7.25 | $6.01 | $5.70 | |
| Shares (Basic) | 908,000,000 | 921,000,000 | 928,000,000 | 937,000,000 | 943,000,000 | 949,000,000 | 951,000,000 | 963,000,000 | 964,000,000 | 952,000,000 | 953,000,000 | 972,000,000 | |
| Shares (Diluted) | 911,000,000 | 929,000,000 | 938,000,000 | 950,000,000 | 956,000,000 | 961,000,000 | 966,000,000 | 983,000,000 | 985,000,000 | 968,000,000 | 967,000,000 | 986,000,000 | |
| EBITDA | $18.96B | $32.29B | $32.36B | $28.43B | $23.97B | $22.41B | $19.68B | $17.34B | $15.21B | $12.93B | $11.02B | $10.27B |
งบดุล 26
| ตัวชี้วัด | แนวโน้ม | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $24.36B | $25.31B | $25.43B | $23.36B | $21.38B | $16.92B | $10.98B | $10.87B | $11.98B | $10.43B | $10.92B | $7.50B | |
| Short-term Investments | $3.76B | $3.80B | $4.20B | $4.55B | $2.53B | $2.86B | $3.26B | $3.46B | $3.51B | $2.85B | $1.99B | $1.74B | |
| Receivables | $23.02B | $22.36B | $21.28B | $17.68B | $14.22B | $12.87B | $11.82B | $11.39B | $9.57B | $8.15B | $6.52B | $4.25B | |
| Inventory | $3.30B | $3.80B | $2.80B | $3.50B | $2.90B | · | · | · | · | · | · | · | |
| Prepaid Expense | $9.75B | $8.21B | $6.08B | $6.62B | $5.32B | $4.46B | $3.85B | $3.09B | $2.66B | $1.85B | $2.41B | $1.05B | |
| Current Assets | $90.58B | $85.78B | $78.44B | $69.07B | $61.76B | $53.72B | $42.63B | $38.69B | $37.08B | $33.88B | $31.64B | $23.56B | |
| PP&E (Net) | $10.76B | $10.55B | $11.45B | $10.13B | $8.97B | $8.63B | $8.70B | $8.46B | $7.01B | $5.90B | $4.86B | $4.42B | |
| Accum. Depreciation | $7.55B | $6.97B | $7.04B | $6.93B | $5.99B | $5.23B | $5.00B | $4.14B | $3.69B | $3.75B | $3.17B | $2.95B | |
| Goodwill | $110.50B | $106.73B | $103.73B | $93.35B | $75.80B | $71.34B | $65.66B | $58.91B | $54.56B | $47.58B | $44.45B | $32.94B | |
| Intangibles | $20.47B | $23.27B | $15.19B | $14.40B | $10.04B | $10.86B | $10.35B | $9.32B | $8.49B | $8.54B | $8.39B | $3.67B | |
| Other Non-current Assets | $23.01B | $19.59B | $17.30B | $15.03B | $12.53B | $11.51B | $9.33B | $4.33B | $3.58B | $3.04B | $3.12B | $2.97B | |
| Total Assets | $309.58B | $298.28B | $273.72B | $245.71B | $212.21B | $197.29B | $173.89B | $152.22B | $139.06B | $122.81B | $111.25B | $86.30B | |
| Accounts Payable | $38.03B | $34.34B | $31.96B | $27.71B | $24.64B | $22.50B | $19.00B | $16.70B | $15.18B | $13.36B | $11.99B | $9.25B | |
| Current Liabilities | $114.90B | $103.77B | $99.05B | $89.24B | $78.29B | $72.42B | $61.78B | $53.21B | $50.46B | $49.25B | $42.90B | $30.62B | |
| Deferred Tax | $2.42B | $3.62B | $3.02B | $2.77B | $3.27B | $3.37B | $2.99B | $2.47B | $2.18B | $2.76B | $3.59B | $2.06B | |
| Other Non-current Liabilities | $18.25B | $15.94B | $14.46B | $12.84B | $11.79B | $12.31B | $10.14B | $5.73B | $5.56B | $4.83B | $1.48B | $1.36B | |
| Total Liabilities | $207.88B | $195.69B | $174.80B | $159.36B | $135.73B | $126.75B | $111.73B | $95.99B | $87.04B | $82.62B | $75.79B | $52.54B | |
| Long-term Debt | · | · | · | · | $46.00B | $43.47B | $40.68B | $36.55B | $31.69B | $32.97B | $31.96B | $17.41B | |
| Total Debt | $72.32B | $72.36B | $58.26B | $54.51B | $46.00B | $43.47B | $40.68B | $36.55B | $31.69B | $32.97B | $32.09B | $17.41B | |
| Common Stock | $9M | $9M | $9M | $9M | $10M | $10M | $9M | $10M | $10M | $10M | $10M | $10M | |
| Paid-in Capital | $559M | $0 | $0 | · | $0 | $0 | $7M | $0 | $1.70B | $0 | $29M | $0 | |
| Retained Earnings | $95.60B | $96.04B | $95.77B | $86.16B | $77.13B | $69.30B | $61.18B | $55.85B | $48.73B | $40.95B | $37.12B | $33.84B | |
| AOCI | $-2.06B | $-3.39B | $-7.03B | $-8.39B | $-5.38B | $-3.81B | $-3.58B | $-4.16B | $-2.67B | $-2.68B | $-3.33B | $-1.39B | |
| Stockholders' Equity | $100.09B | $98.27B | $94.42B | $81.45B | $75.05B | $68.33B | $60.44B | $54.32B | $49.83B | $38.18B | $33.73B | $32.45B | |
| Liabilities + Equity | $309.58B | $298.28B | $273.72B | $245.71B | $212.21B | $197.29B | $173.89B | $152.22B | $139.06B | $122.81B | $111.25B | $86.38B | |
| Shares Outstanding | 906,000,000 | 915,000,000 | 924,000,000 | 934,000,000 | 941,000,000 | 946,000,000 | 948,000,000 | 960,000,000 | 969,000,000 | 952,000,000 | 953,000,000 | 954,000,000 |
กระแสเงินสด 18
| ตัวชี้วัด | แนวโน้ม | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4.36B | $4.10B | $3.97B | $3.40B | $3.10B | $2.89B | $2.72B | $2.43B | $2.25B | $2.06B | $1.69B | $1.48B | |
| Stock-based Comp | $971M | $1.02B | $1.06B | $925M | $800M | $679M | $697M | $638M | $597M | $485M | $406M | $364M | |
| Deferred Tax | $-1.75B | $-296M | $-245M | $-673M | $130M | $-8M | $230M | $42M | $-965M | $81M | $-73M | $-117M | |
| Amort. of Intangibles | $1.70B | $1.70B | $1.60B | $1.30B | $1.20B | $1.10B | $1.00B | $898M | $896M | $882M | $650M | $524M | |
| Operating Cash Flow | $19.70B | $24.20B | $29.07B | $26.21B | $22.34B | $22.17B | $18.46B | $15.71B | $13.60B | $9.79B | $9.74B | $8.05B | |
| CapEx | $3.62B | $3.50B | $3.39B | $2.80B | $2.45B | $2.05B | $2.07B | $2.06B | $2.02B | $1.71B | $1.56B | $1.52B | |
| Investing Cash Flow | $-8.69B | $-20.53B | $-15.57B | $-28.48B | $-10.37B | $-12.53B | $-12.70B | $-12.38B | $-8.60B | $-9.36B | $-18.39B | $-2.53B | |
| Debt Issued | $2.97B | $17.81B | $6.39B | $14.82B | $6.93B | $4.86B | $5.44B | $6.93B | $5.29B | $3.97B | $11.98B | $2.00B | |
| Net Debt Issued | $-81M | $14.81B | $4.27B | $11.80B | $3.78B | $1.71B | $3.69B | $4.33B | $893M | $1.37B | $10.94B | $1.19B | |
| Stock Issued | $827M | $1.85B | $1.35B | $1.25B | $1.35B | $1.44B | $1.04B | $838M | $688M | $429M | $402M | $462M | |
| Stock Repurchased | $5.54B | $9.00B | $8.00B | $7.00B | $5.00B | $4.25B | $5.50B | $4.50B | $1.50B | $1.28B | $1.20B | $4.01B | |
| Net Stock Activity | $-4.72B | $-7.15B | $-6.65B | $-5.75B | $-3.65B | $-2.81B | $-4.46B | $-3.66B | $-812M | $-851M | $-798M | $-3.55B | |
| Dividends Paid | $7.92B | $7.53B | $6.76B | $5.99B | $5.28B | $4.58B | $3.93B | $3.32B | $2.77B | $2.26B | $1.79B | $1.36B | |
| Financing Cash Flow | $-11.64B | $-3.51B | $-11.53B | $4.23B | $-7.46B | $-3.59B | $-5.62B | $-4.37B | $-3.44B | $-1.01B | $12.24B | $-5.29B | |
| Net Change in Cash | $-947M | $-115M | $2.06B | $1.99B | $4.45B | $5.94B | $119M | $-1.11B | $1.55B | $-493M | $3.43B | $219M | |
| Taxes Paid | $3.71B | $4.62B | $6.08B | $5.22B | $3.97B | $4.93B | $3.54B | $3.26B | $4.00B | $4.73B | $4.40B | $4.02B | |
| Free Cash Flow | $16.07B | $20.70B | $25.68B | $23.40B | $19.89B | $20.12B | $16.39B | $13.65B | $11.57B | $8.09B | $8.18B | $6.53B | |
| Levered FCF | $12.59B | $17.74B | $23.10B | $21.76B | $18.57B | $18.86B | $15.04B | $12.56B | $10.66B | $7.45B | $7.73B | $6.17B |
ความสามารถในการทำกำไร 7
| ตัวชี้วัด | แนวโน้ม | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 4.2% | 8.1% | 8.7% | 8.8% | 8.3% | 8.7% | 8.1% | 7.7% | 7.6% | 7.0% | 7.0% | 7.9% | |
| Net Margin | 2.7% | 3.6% | 6.0% | 6.2% | 6.0% | 6.0% | 5.7% | 5.3% | 5.2% | 3.8% | 3.7% | 4.3% | |
| Pretax Margin | 3.3% | 5.0% | 7.8% | 8.1% | 7.8% | 8.1% | 7.4% | 7.0% | 7.0% | 6.4% | 6.5% | 7.4% | |
| EBITDA Margin | 4.2% | 8.1% | 8.7% | 8.8% | 8.3% | 8.7% | 8.1% | 7.7% | 7.6% | 7.0% | 7.0% | 7.9% | |
| ROA | 4.0% | 4.8% | 8.6% | 8.8% | 8.4% | 8.3% | 8.5% | 8.2% | 8.1% | 6.0% | 5.9% | 6.7% | |
| ROE | 12.0% | 14.5% | 24.3% | 25.2% | 23.3% | 22.6% | 23.4% | 22.4% | 21.7% | 18.5% | 17.4% | 17.3% | |
| ROIC | 9.6% | 14.4% | 16.9% | 16.4% | 15.7% | 15.2% | 15.4% | 14.8% | 14.4% | 10.8% | 9.6% | 12.0% |
สภาพคล่องและความสามารถในการชำระหนี้ 5
| ตัวชี้วัด | แนวโน้ม | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.8 | |
| Quick Ratio | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.4 | 0.5 | 0.5 | 0.4 | 0.5 | 0.4 | |
| Debt / Equity | 0.7 | 0.7 | 0.6 | 0.7 | 0.6 | 0.6 | 0.7 | 0.7 | 0.6 | 0.9 | 1.0 | 0.5 | |
| LT Debt / Equity | 0.7 | 0.7 | 0.6 | 0.7 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.7 | 0.8 | 0.5 | |
| Interest Coverage | 4.7 | 8.3 | 10.0 | 13.6 | 14.4 | 13.5 | 11.6 | 12.4 | 12.8 | 12.1 | 14.0 | 16.6 |
ประสิทธิภาพ 3
| ตัวชี้วัด | แนวโน้ม | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.5 | 1.3 | 1.4 | 1.4 | 1.4 | 1.4 | 1.5 | 1.6 | 1.5 | 1.6 | 1.6 | 1.6 | |
| Inventory Turnover | 14.3 | 14.1 | 12.3 | 10.5 | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 19.7 | 18.3 | 19.1 | 20.3 | 21.2 | 20.8 | 20.9 | 21.6 | 22.7 | 25.2 | 29.2 | 35.7 |
อัตราการเติบโต 10
| ตัวชี้วัด | แนวโน้ม | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.8% | 7.7% | 14.6% | 12.7% | 11.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 11.3% | 11.7% | 13.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.7% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -14.7% | -35.0% | 12.7% | 17.2% | 12.8% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -14.5% | -5.0% | 14.2% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -3.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -16.3% | -35.6% | 11.2% | 16.4% | 12.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -15.7% | -5.9% | 13.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -4.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 11.6% | · | · | · | · | · | · | · | · | · | · | · |
การประเมินมูลค่า (TTM) 16
| ตัวชี้วัด | แนวโน้ม | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $447.57B | $400.28B | $371.62B | $324.16B | $287.60B | $257.14B | $242.16B | $226.25B | $201.16B | $184.84B | $157.11B | $130.47B | |
| Net Income TTM | $12.06B | $14.40B | $22.38B | $20.12B | $17.29B | $15.40B | $13.84B | $11.99B | $10.56B | $7.02B | $5.81B | $5.62B | |
| Market Cap | $299.08B | $462.86B | $486.46B | $495.19B | $472.51B | $331.74B | $278.69B | $239.16B | $213.63B | $152.36B | $112.11B | $96.44B | |
| Enterprise Value | $343.28B | $506.11B | $515.09B | $521.79B | $494.61B | $355.43B | $305.13B | $261.39B | $229.83B | $172.05B | $131.29B | $104.61B | |
| P/E | 25.0 | 32.6 | 22.1 | 25.0 | 27.8 | 21.9 | 20.5 | 20.4 | 20.6 | 22.1 | 19.6 | 17.7 | |
| P/S | 0.7 | 1.2 | 1.3 | 1.5 | 1.6 | 1.3 | 1.2 | 1.1 | 1.1 | 0.8 | 0.7 | 0.7 | |
| P/B | 3.0 | 4.7 | 5.2 | 6.1 | 6.3 | 4.9 | 4.6 | 4.4 | 4.3 | 4.0 | 3.3 | 3.0 | |
| P / Cash Flow | 15.2 | 19.1 | 16.7 | 18.9 | 21.1 | 15.0 | 15.1 | 15.2 | 15.7 | 15.6 | 11.5 | 12.0 | |
| P / FCF | 18.6 | 22.4 | 18.9 | 21.2 | 23.8 | 16.5 | 17.0 | 17.5 | 18.5 | 18.8 | 13.7 | 14.8 | |
| EV / EBITDA | 18.1 | 15.7 | 15.9 | 18.4 | 20.6 | 15.9 | 15.5 | 15.1 | 15.1 | 13.3 | 11.9 | 10.2 | |
| EV / FCF | 21.4 | 24.4 | 20.1 | 22.3 | 24.9 | 17.7 | 18.6 | 19.1 | 19.9 | 21.3 | 16.0 | 16.0 | |
| EV / Revenue | 0.8 | 1.3 | 1.4 | 1.6 | 1.7 | 1.4 | 1.3 | 1.2 | 1.1 | 0.9 | 0.8 | 0.8 | |
| Dividend Yield | 2.6% | 1.6% | 1.4% | 1.2% | 1.1% | 1.4% | 1.4% | 1.4% | 1.3% | 1.5% | 1.6% | 1.4% | |
| Earnings Yield | 4.0% | 3.1% | 4.5% | 4.0% | 3.6% | 4.6% | 4.9% | 4.9% | 4.9% | 4.5% | 5.1% | 5.6% | |
| Payout Ratio | 65.7% | 52.3% | 30.2% | 29.8% | 30.6% | 29.8% | 28.4% | 27.7% | 26.3% | 32.2% | 30.7% | 24.2% | |
| Annual Payout | $7.92B | $7.53B | $6.76B | $5.99B | $5.28B | $4.58B | $3.93B | $3.32B | $2.77B | $2.26B | $1.79B | $1.36B |
งบกำไรขาดทุน 14
| ตัวชี้วัด | แนวโน้ม | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $112.03B | $111.72B | $113.22B | $113.16B | $111.62B | $109.58B | $100.81B | $100.82B | $98.86B | $99.80B | $94.43B | $92.36B | $92.90B | $91.93B | $82.79B | $80.89B | |
| Cost of Revenue | $13.38B | $12.82B | $12.68B | $12.57B | $13.02B | $12.39B | $12.46B | $11.83B | $11.34B | $11.06B | $10.19B | $9.42B | $9.75B | $9.40B | $8.31B | $8.31B | |
| SG&A Expense | $14.27B | $15.39B | $17.00B | $15.22B | $13.78B | $13.59B | $12.49B | $13.28B | $13.16B | $14.08B | $13.34B | $13.86B | $13.81B | $13.62B | $13.01B | $11.66B | |
| Operating Expenses | $104.04B | $102.73B | $112.83B | $108.85B | $106.47B | $100.46B | $93.03B | $92.11B | $90.98B | $91.86B | $86.74B | $83.83B | $84.85B | $83.84B | $75.90B | $73.43B | |
| Operating Income | $7.99B | $8.99B | $380M | $4.32B | $5.15B | $9.12B | $7.77B | $8.71B | $7.88B | $7.93B | $7.69B | $8.53B | $8.06B | $8.09B | $6.89B | $7.46B | |
| Interest Expense | $962M | $955M | $974M | $1.00B | $1.03B | $998M | $1.00B | $1.07B | $985M | $844M | $830M | $834M | $828M | $754M | $676M | $516M | |
| Pretax Income | $6.97B | $7.96B | $-720M | $3.23B | $4.08B | $8.11B | $6.79B | $7.61B | $5.67B | $1M | $6.86B | $7.69B | $7.23B | $7.33B | $6.21B | $6.95B | |
| Income Tax | $1.30B | $1.48B | $-938M | $686M | $510M | $1.63B | $1.01B | $1.36B | $1.24B | $1.22B | $1.18B | $1.65B | $1.57B | $1.56B | $1.31B | $1.56B | |
| Net Income | $5.48B | $6.28B | $10M | $2.35B | $3.41B | $6.29B | $5.54B | $6.05B | $4.22B | $-1.41B | $5.46B | $5.84B | $5.47B | $5.61B | $4.76B | $5.26B | |
| EPS (Basic) | $6.06 | $6.92 | $0.03 | $2.59 | $3.76 | $6.90 | $6.03 | $6.56 | $4.58 | $-1.53 | $5.91 | $6.31 | $5.89 | $6.01 | $5.09 | $5.63 | |
| EPS (Diluted) | $6.04 | $6.90 | $0.05 | $2.59 | $3.74 | $6.85 | $5.99 | $6.51 | $4.54 | $-1.53 | $5.85 | $6.24 | $5.82 | $5.95 | $5.02 | $5.55 | |
| Shares (Basic) | 902,000,000 | 908,000,000 | -1,817,000,000 | 906,000,000 | 907,000,000 | 912,000,000 | -1,845,000,000 | 923,000,000 | 921,000,000 | 922,000,000 | -1,861,000,000 | 926,000,000 | 930,000,000 | 933,000,000 | -1,876,000,000 | 935,000,000 | |
| Shares (Diluted) | 906,000,000 | 910,000,000 | -1,825,000,000 | 908,000,000 | 910,000,000 | 918,000,000 | -1,851,000,000 | 930,000,000 | 928,000,000 | 922,000,000 | -1,881,000,000 | 936,000,000 | 940,000,000 | 943,000,000 | -1,902,000,000 | 948,000,000 | |
| EBITDA | $7.99B | $8.99B | · | $4.32B | $5.15B | $9.12B | · | $8.71B | $7.88B | $7.93B | · | $8.53B | $8.06B | $8.09B | · | $7.46B |
งบดุล 26
| ตัวชี้วัด | แนวโน้ม | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $28.59B | $28.00B | $24.36B | $27.21B | $28.60B | $30.72B | $25.31B | $32.40B | $26.29B | $28.41B | · | $38.91B | $41.81B | $41.91B | · | $38.84B | |
| Short-term Investments | $2.88B | $3.23B | $3.76B | $3.40B | $3.42B | $3.57B | $3.80B | $4.73B | $5.04B | $4.30B | · | $5.18B | $4.47B | $4.58B | · | $3.68B | |
| Receivables | $21.57B | $26.59B | $23.02B | $22.67B | $24.14B | $26.94B | $22.36B | $20.02B | $23.11B | $27.20B | · | $20.67B | $17.95B | $22.41B | · | $17.05B | |
| Inventory | · | · | $3.30B | · | · | · | $3.80B | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $9.10B | $8.72B | $9.75B | $9.02B | $8.96B | $9.04B | $8.21B | $7.64B | $7.42B | $6.13B | · | $5.77B | $5.88B | $6.45B | · | $5.66B | |
| Current Assets | $86.86B | $91.13B | $90.58B | $95.07B | $93.70B | $96.28B | $85.78B | $92.26B | $92.04B | $88.94B | · | $91.91B | $89.87B | $93.89B | · | $82.94B | |
| PP&E (Net) | $10.76B | $10.67B | $10.76B | $11.10B | $10.92B | $10.73B | $10.55B | $10.14B | $9.80B | $10.43B | · | $11.07B | $10.93B | $10.64B | · | $9.47B | |
| Accum. Depreciation | · | · | $7.55B | · | · | · | $6.97B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $110.64B | $110.51B | $110.50B | $110.34B | $107.68B | $107.57B | $106.73B | $105.98B | $105.44B | $105.66B | $103.73B | $101.70B | $101.67B | $100.41B | $93.35B | $83.90B | |
| Intangibles | $19.75B | $20.09B | $20.47B | $22.79B | $22.51B | $22.95B | $23.27B | $23.59B | $14.73B | $15.54B | · | $15.20B | $15.64B | $16.16B | · | $10.79B | |
| Other Non-current Assets | $24.00B | $23.46B | $23.01B | $22.98B | $21.30B | $20.39B | $19.59B | $18.65B | $17.94B | $17.70B | · | $16.71B | $16.07B | $15.69B | · | $14.41B | |
| Total Assets | $309.73B | $312.64B | $309.58B | $315.27B | $308.57B | $309.79B | $298.28B | $299.31B | $286.06B | $284.21B | $273.72B | $282.06B | $280.16B | $283.68B | $245.71B | $243.06B | |
| Accounts Payable | $39.74B | $38.63B | $38.03B | $36.03B | $34.33B | $33.57B | $34.34B | $33.08B | $30.89B | $30.74B | · | $31.16B | $29.52B | $29.86B | · | $27.23B | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | $7.30B | · | $2.60B | $4.40B | $8.20B | · | · | |
| Current Liabilities | $111.82B | $114.12B | $114.90B | $115.53B | $110.78B | $113.47B | $103.77B | $101.56B | $104.67B | $104.43B | · | $114.18B | $112.98B | $116.48B | · | $100.94B | |
| Deferred Tax | $2.72B | $2.86B | $2.42B | $3.16B | $3.80B | $3.90B | $3.62B | $4.01B | $3.63B | $4.17B | · | $2.21B | $2.50B | $2.83B | · | $1.66B | |
| Other Non-current Liabilities | $19.73B | $18.90B | $18.25B | $18.37B | $15.71B | $15.96B | $15.94B | $15.17B | $14.79B | $14.84B | · | $13.62B | $13.26B | $13.08B | · | $12.11B | |
| Total Liabilities | $203.78B | $207.32B | $207.88B | $209.46B | $203.79B | $204.62B | $195.69B | $194.85B | $186.82B | $187.29B | · | $188.08B | $188.01B | $193.06B | · | $160.14B | |
| Total Debt | $69.50B | $71.44B | · | $72.40B | $73.50B | $71.28B | · | $74.10B | $63.73B | $71.15B | · | $60.68B | $63.67B | $68.86B | · | $45.44B | |
| Common Stock | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | · | $9M | $9M | $9M | · | $10M | |
| Paid-in Capital | $0 | $556M | $559M | $394M | · | · | $0 | $461M | $373M | · | · | · | · | · | · | · | |
| Retained Earnings | $100.96B | $99.88B | $95.60B | $97.59B | $97.25B | $97.93B | $96.04B | $96.52B | $92.40B | $90.12B | · | $93.17B | $89.99B | $88.85B | · | $83.72B | |
| AOCI | $-2.52B | $-2.56B | $-2.06B | $-2.21B | $-2.54B | $-2.90B | $-3.39B | $-2.45B | $-3.42B | $-3.44B | · | $-8.69B | $-7.65B | $-7.55B | · | $-9.09B | |
| Stockholders' Equity | $104.51B | $103.89B | $100.09B | $101.57B | $100.47B | $100.81B | $98.27B | $99.88B | $94.68B | $92.37B | $94.42B | $89.56B | $87.37B | $85.82B | $81.45B | $78.06B | |
| Liabilities + Equity | $309.73B | $312.64B | $309.58B | $315.27B | $308.57B | $309.79B | $298.28B | $299.31B | $286.06B | $284.21B | · | $282.06B | $280.16B | $283.68B | · | $243.06B | |
| Shares Outstanding | 905,000,000 | 908,000,000 | 906,000,000 | 906,000,000 | 905,000,000 | 910,000,000 | 915,000,000 | 923,000,000 | 921,000,000 | 920,000,000 | 924,000,000 | 925,000,000 | 927,000,000 | 932,000,000 | 934,000,000 | 935,000,000 |
กระแสเงินสด 16
| ตัวชี้วัด | แนวโน้ม | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.04B | $1.03B | $1.12B | $1.10B | $1.08B | $1.06B | $1.04B | $1.04B | $1.02B | $997M | $974M | $1.01B | $1.02B | $970M | $982M | $828M | |
| Stock-based Comp | $276M | $348M | $176M | $223M | $197M | $375M | $187M | $237M | $222M | $372M | $208M | $247M | $242M | $362M | $250M | $171M | |
| Deferred Tax | $-129M | $540M | $-733M | $-932M | $-151M | $64M | $-62M | $124M | $-331M | $-27M | $249M | $-12M | $-150M | $-332M | $-83M | $-575M | |
| Operating Cash Flow | $11.05B | $8.91B | $1.11B | $5.95B | $7.19B | $5.46B | $2.37B | $13.95B | $6.75B | $1.14B | $-5.19B | $6.90B | $11.03B | $16.33B | $-4.53B | $18.55B | |
| CapEx | $799M | $763M | $948M | $890M | $886M | $898M | $912M | $991M | $853M | $743M | $959M | $838M | $829M | $760M | $866M | $724M | |
| Investing Cash Flow | $-1.80B | $-2.45B | $-2.61B | $-4.56B | $-1.44B | $-74M | $-1.12B | $-5.65B | $-7.42B | $-6.34B | $-1.19B | $-2.64B | $-728M | $-11.02B | $-15.37B | $-847M | |
| Debt Issued | · | · | $0 | $0 | $2.97B | $0 | $0 | $11.89B | $0 | $5.92B | $0 | $0 | $-7M | $6.40B | $8.90B | $0 | |
| Net Debt Issued | · | $-1.50B | · | · | · | $0 | · | · | · | $5.17B | · | · | · | $5.03B | · | · | |
| Stock Issued | $128M | $231M | $24M | $222M | $221M | $360M | $235M | $867M | $258M | $486M | $314M | $411M | $284M | $344M | $169M | $328M | |
| Stock Repurchased | $1.65B | $0 | $0 | $0 | $2.54B | $3.00B | $4.97B | $956M | $0 | $3.07B | $1.50B | $1.50B | $3.00B | $2.00B | $1.00B | $1.00B | |
| Net Stock Activity | · | $231M | · | · | · | $-2.64B | · | · | · | $-2.59B | · | · | · | $-1.66B | · | · | |
| Dividends Paid | $2.09B | $2.00B | $2.00B | $2.00B | $2.00B | $1.91B | $1.93B | $1.94B | $1.94B | $1.73B | $1.74B | $1.74B | $1.75B | $1.54B | $1.54B | $1.54B | |
| Financing Cash Flow | $-8.62B | $-2.99B | $-1.03B | $-2.77B | $-7.95B | $99M | $-8.34B | $-2.21B | $-1.20B | $8.23B | $-7.16B | $-7.10B | $-10.46B | $13.19B | $4.39B | $-3.42B | |
| Net Change in Cash | $584M | $3.64B | $-2.85B | $-1.39B | $-2.12B | $5.41B | $-7.09B | $6.11B | $-2.13B | $2.99B | $-13.49B | $-2.90B | $-100M | $18.55B | $-15.48B | $14.23B | |
| Free Cash Flow | · | $8.15B | · | · | · | $4.56B | · | · | · | $401M | · | · | · | $15.57B | · | · | |
| Levered FCF | · | $7.37B | · | · | · | $3.76B | · | · | · | $1.03T | · | · | · | $14.97B | · | · |
ความสามารถในการทำกำไร 7
| ตัวชี้วัด | แนวโน้ม | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 7.1% | 8.1% | · | 3.8% | 4.6% | 8.3% | · | 8.6% | 8.0% | 8.0% | · | 9.2% | 8.7% | 8.8% | · | 9.2% | |
| Net Margin | 4.9% | 5.6% | · | 2.1% | 3.0% | 5.7% | · | 6.0% | 4.3% | -1.4% | · | 6.3% | 5.9% | 6.1% | · | 6.5% | |
| Pretax Margin | 6.2% | 7.1% | · | 2.9% | 3.7% | 7.4% | · | 7.5% | 5.7% | 0.00% | · | 8.3% | 7.8% | 8.0% | · | 8.6% | |
| EBITDA Margin | 7.1% | 8.1% | · | 3.8% | 4.6% | 8.3% | · | 8.6% | 8.0% | 8.0% | · | 9.2% | 8.7% | 8.8% | · | 9.2% | |
| ROA | 1.8% | 2.0% | · | 0.76% | 1.1% | 2.1% | · | 2.1% | 1.5% | -0.50% | · | 2.2% | 2.1% | 2.2% | · | 2.3% | |
| ROE | 5.3% | 6.1% | · | 2.3% | 3.5% | 6.5% | · | 6.4% | 4.6% | -1.6% | · | 7.0% | 6.7% | 6.9% | · | 7.0% | |
| ROIC | 3.7% | 4.2% | · | 1.9% | 2.6% | 4.2% | · | 4.1% | 3.9% | -5922.1% | · | 4.5% | 4.2% | 4.1% | · | 4.7% |
สภาพคล่องและความสามารถในการชำระหนี้ 5
| ตัวชี้วัด | แนวโน้ม | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.9 | 0.9 | 0.9 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | |
| Quick Ratio | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.5 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | |
| Debt / Equity | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | |
| LT Debt / Equity | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.6 | 0.7 | 0.7 | · | 0.6 | |
| Interest Coverage | 8.3 | 9.4 | · | 4.3 | 5.0 | 9.1 | · | 8.1 | 8.0 | 9.4 | · | 10.2 | 9.7 | 10.7 | · | 14.5 |
ประสิทธิภาพ 2
| ตัวชี้วัด | แนวโน้ม | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.3 | 0.3 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| Receivables Turnover | 4.9 | 4.2 | · | 5.3 | 4.7 | 4.0 | · | 5.0 | 4.8 | 4.0 | · | 4.9 | 5.1 | 4.5 | · | 5.2 |
การประเมินมูลค่า (TTM) 14
| ตัวชี้วัด | แนวโน้ม | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $448.53B | $446.07B | · | $435.17B | $420.87B | $409.05B | · | $391.83B | $383.92B | $376.99B | · | $358.09B | $346.06B | $333.31B | · | $313.71B | |
| Net Income TTM | $17.52B | $18.33B | · | $18.10B | $19.97B | $15.15B | · | $14.70B | $14.12B | $15.52B | · | $22.19B | $21.42B | $20.97B | · | $19.45B | |
| Market Cap | $376.15B | $245.70B | · | $312.84B | $282.33B | $476.61B | · | $539.66B | $469.03B | $455.12B | · | $466.38B | $445.55B | $440.45B | · | $472.21B | |
| Enterprise Value | $414.18B | $285.91B | · | $354.63B | $323.81B | $513.61B | · | $576.63B | $501.43B | $493.56B | · | $482.96B | $462.94B | $462.81B | · | $475.12B | |
| P/E | 21.6 | 13.5 | · | 17.5 | 14.4 | 32.0 | · | 37.1 | 33.8 | 30.0 | · | 21.4 | 21.2 | 21.4 | · | 24.7 | |
| P/S | 0.8 | 0.6 | · | 0.7 | 0.7 | 1.2 | · | 1.4 | 1.2 | 1.2 | · | 1.3 | 1.3 | 1.3 | · | 1.5 | |
| P/B | 3.6 | 2.4 | · | 3.1 | 2.8 | 4.7 | · | 5.4 | 5.0 | 4.9 | · | 5.2 | 5.1 | 5.1 | · | 6.0 | |
| P / Cash Flow | · | 27.6 | · | · | · | 87.4 | · | · | · | 397.8 | · | · | · | 27.0 | · | · | |
| P / FCF | · | 30.2 | · | · | · | 104.6 | · | · | · | 1135.0 | · | · | · | 28.3 | · | · | |
| EV / EBITDA | 51.8 | 31.8 | · | 82.2 | 62.9 | 56.3 | · | 66.2 | 63.7 | 62.2 | · | 56.6 | 57.5 | 57.2 | · | 63.7 | |
| EV / FCF | · | 35.1 | · | · | · | 112.7 | · | · | · | 1230.8 | · | · | · | 29.7 | · | · | |
| EV / Revenue | 0.9 | 0.6 | · | 0.8 | 0.8 | 1.3 | · | 1.5 | 1.3 | 1.3 | · | 1.3 | 1.3 | 1.4 | · | 1.5 | |
| Earnings Yield | 4.6% | 7.4% | · | 5.7% | 6.9% | 3.1% | · | 2.7% | 3.0% | 3.3% | · | 4.7% | 4.7% | 4.7% | · | 4.0% | |
| Payout Ratio | · | 31.9% | · | · | · | 30.4% | · | · | · | -122.7% | · | · | · | 27.4% | · | · |
งบการเงิน งบกำไรขาดทุน, งบดุล, งบกระแสเงินสด — รายปี, 5 ปีล่าสุด
งบกำไรขาดทุน
| 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| รายได้ | $447.57B | — | — | $400.28B | — |
| อัตรากำไรจากการดำเนินงาน % | 4.2% | — | — | 8.1% | — |
| กำไรสุทธิ | $12.06B | — | — | $14.40B | — |
| EPS ที่ปรับลดแล้ว | $13.23 | — | — | $15.51 | — |
งบดุล
| 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| หนี้สินต่อทุน | 0.7 | — | — | 0.7 | — |
| อัตราส่วนสภาพคล่อง | 0.8 | — | — | 0.8 | — |
| อัตราส่วนเงินสด | 0.4 | — | — | 0.5 | — |
กระแสเงินสด
| 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| กระแสเงินสดอิสระ | $16.07B | — | — | $20.70B | — |
ข่าวล่าสุด หัวข้อข่าวล่าสุดที่กล่าวถึงบริษัทนี้
- หุ้น United Health ยังคงมีมูลค่าต่ำกว่าที่ควรหรือไม่?
- UnitedHealth Lost Nearly 1 Million Medicare Members. Here's Why Investors Aren't Worried
- UnitedHealth Group boosts earnings outlook after stronger-than-expected Q2 results
- UnitedHealth Group น่าซื้อหรือไม่ หลังรายงานผลประกอบการล่าสุด?
- JPMorgan Raises its Price Target on UnitedHealth Group (UNH)
- UnitedHealth Stock Jumps on Upgrade From Bank of America. UNH Is No Longer Just an Insurance Company.
- รายงานเงินปันผลประจำวัน: MDT,ACM,UNH,RICK,VRT
- ยักษ์ใหญ่ด้านการดูแลสุขภาพกำลังกลายเป็นผู้ทรงพลังด้าน AI อย่างเงียบๆ
- UnitedHealth Group (UNH) – หนึ่งใน 10 หุ้นคุณภาพสูงที่ควรซื้อตามการประเมินของ Hedge Funds
- หุ้น UnitedHealth (UNH) ร่วง หลัง Berkshire Hathaway ถอนการลงทุน อ้างอิงจาก Reuters
สัญญาณซื้อขาย สัญญาณซื้อ/ขายล่าสุดพร้อมราคาเข้าและอัตราส่วนความเสี่ยง/ผลตอบแทน
ตัวชี้วัดของฉัน รายการเฝ้าดูส่วนตัวของคุณ — แถวที่เลือกจากข้อมูลพื้นฐานฉบับเต็ม
เลือกเมตริกที่สำคัญสำหรับคุณ — คลิก ➕ ถัดจากแถวใดก็ได้ในข้อมูลพื้นฐานฉบับเต็มด้านบน
การเลือกของคุณถูกบันทึกและจะติดตามคุณไปในทุกสัญลักษณ์หุ้น
ผู้ถือครองสถาบัน (13F) 3,752 รายงาน · $243.5B ทั้งหมด · ณ วันที่ 30 มิถุนายน 2026
สถาบันที่รายงานการถือครองหุ้นนี้ในเอกสาร SEC Form 13F รายไตรมาสของตน เฉพาะสถานะ Long; ผู้ยื่นคำร้องรายเดียวอาจปรากฏสองครั้งสำหรับสัญญาออปชันที่แยกจากกัน ขา put/call ขนาดใหญ่ที่หักล้างกันมักสะท้อนถึงการทำตลาด (market-making) หรือสินค้าคงคลังที่มีการป้องกันความเสี่ยง (hedged inventory) ไม่ใช่การเชื่อมั่นในทิศทาง
| พอร์ตใหม่ | ตำแหน่งที่ปิดไปแล้ว | เพิ่มขึ้น | ลดลง | การเปลี่ยนแปลงสุทธิของจำนวนหุ้น |
|---|---|---|---|---|
| 513 (+264 เทียบกับไตรมาสก่อน) | 121 (-257 เทียบกับไตรมาสก่อน) | 1,267 (+54 เทียบกับไตรมาสก่อน) | 1,278 (-102 เทียบกับไตรมาสก่อน) | +117.7M |
เปรียบเทียบกับ Q1 2026. การยื่นแบบฟอร์ม 13F ของ SEC จะครบกำหนดภายใน 45 วันนับจากสิ้นสุดไตรมาส บวกกับระยะเวลาผ่อนผันสั้นๆ สำหรับผู้ยื่นล่าช้า — ไตรมาสที่ยังอยู่ในช่วงเวลานี้จะถูกข้ามไปเพื่อใช้คู่ที่รายงานล่าสุดอย่างสมบูรณ์
| สถาบัน | มูลค่า | หุ้น | % ของ 13F ที่ติดตาม | ประเภท |
|---|---|---|---|---|
| VANGUARD GROUP INC | $27,207,979,474 | 82,420,949 | 11.17% | หุ้น |
| VANGUARD CAPITAL MANAGEMENT LLC | $24,651,649,136 | 59,311,525 | 10.12% | หุ้น |
| STATE STREET CORP | $18,966,554,763 | 45,633,267 | 7.79% | หุ้น |
| Capital World Investors | $12,422,776,956 | 29,887,932 | 5.10% | หุ้น |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $10,175,966,547 | 24,483,234 | 4.18% | หุ้น |
| GEODE CAPITAL MANAGEMENT, LLC | $7,770,611,877 | 18,774,463 | 3.19% | หุ้น |
| FMR LLC | $7,185,101,298 | 17,287,254 | 2.95% | หุ้น |
| NORGES BANK | $5,293,868,088 | 12,736,973 | 2.17% | หุ้น |
| Capital Research Global Investors | $4,378,631,657 | 10,534,177 | 1.80% | หุ้น |
| WELLINGTON MANAGEMENT GROUP LLP | $4,210,086,678 | 10,129,410 | 1.73% | หุ้น |
| Fisher Asset Management, LLC | $3,774,863,715 | 9,082,269 | 1.55% | หุ้น |
| Dodge & Cox | $3,770,702,593 | 9,072,258 | 1.55% | หุ้น |
| Capital International Investors | $3,237,872,783 | 7,789,028 | 1.33% | หุ้น |
| JANE STREET GROUP, LLC | $3,165,978,399 | 7,617,300 | 1.30% | สัญญาซื้อล่วงหน้า |
| Sanders Capital, LLC | $2,451,649,249 | 5,898,634 | 1.01% | หุ้น |
| EAGLE CAPITAL MANAGEMENT LLC | $2,399,442,912 | 5,773,026 | 0.99% | หุ้น |
| VANGUARD FIDUCIARY TRUST CO | $2,119,167,278 | 5,098,687 | 0.87% | หุ้น |
| ALLIANCEBERNSTEIN L.P. | $2,075,268,358 | 7,669,420 | 0.85% | หุ้น |
| MORGAN STANLEY | $2,055,731,816 | 4,946,062 | 0.84% | หุ้น |
| JANE STREET GROUP, LLC | $2,055,124,098 | 4,944,600 | 0.84% | สัญญาขายล่วงหน้า |
| DIMENSIONAL FUND ADVISORS LP | $1,717,292,161 | 4,131,778 | 0.71% | หุ้น |
| BNP PARIBAS FINANCIAL MARKETS | $1,526,781,892 | 3,673,416 | 0.63% | หุ้น |
| AMERIPRISE FINANCIAL INC | $1,405,176,851 | 3,380,319 | 0.58% | หุ้น |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $1,251,138,985 | 3,010,223 | 0.51% | หุ้น |
| Grantham, Mayo, Van Otterloo & Co. LLC | $1,174,164,878 | 2,825,022 | 0.48% | หุ้น |
| BlackRock, Inc. | $1,158,005,862 | 2,786,146 | 0.48% | หุ้น |
| UBS Group AG | $1,092,471,817 | 2,628,472 | 0.45% | สัญญาซื้อล่วงหน้า |
| BANK OF AMERICA CORP /DE/ | $1,087,853,337 | 2,617,360 | 0.45% | หุ้น |
| Mitsubishi UFJ Asset Management Co., Ltd. | $1,065,664,884 | 2,563,973 | 0.44% | หุ้น |
| Swiss National Bank | $1,064,029,841 | 2,560,041 | 0.44% | หุ้น |
| Sumitomo Mitsui Trust Group, Inc. | $1,055,107,927 | 2,538,575 | 0.43% | หุ้น |
| CANADA PENSION PLAN INVESTMENT BOARD | $971,757,071 | 2,338,034 | 0.40% | หุ้น |
| BARCLAYS PLC | $897,842,266 | 2,160,196 | 0.37% | หุ้น |
| RAYMOND JAMES FINANCIAL INC | $874,984,816 | 2,105,201 | 0.36% | หุ้น |
| Walleye Trading LLC | $861,060,671 | 2,071,700 | 0.35% | สัญญาขายล่วงหน้า |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $860,919,095 | 2,071,359 | 0.35% | หุ้น |
| VANGUARD ASSET MANAGEMENT, Ltd | $847,773,811 | 2,039,732 | 0.35% | หุ้น |
| Walleye Trading LLC | $845,183,605 | 2,033,500 | 0.35% | สัญญาซื้อล่วงหน้า |
| Vanguard Global Advisers, LLC | $819,257,021 | 1,971,121 | 0.34% | หุ้น |
| National Pension Service | $818,929,089 | 1,970,332 | 0.34% | หุ้น |
| WOLVERINE TRADING, LLC | $815,453,232 | 2,362,400 | 0.33% | สัญญาซื้อล่วงหน้า |
| ENVESTNET ASSET MANAGEMENT INC | $811,129,699 | 1,951,573 | 0.33% | หุ้น |
| California Public Employees Retirement System | $799,750,674 | 1,924,189 | 0.33% | หุ้น |
| Pentwater Capital Management LP | $777,228,100 | 1,870,000 | 0.32% | สัญญาซื้อล่วงหน้า |
| Legal & General Group Plc | $771,950,431 | 1,857,302 | 0.32% | หุ้น |
| HSBC HOLDINGS PLC | $751,372,125 | 1,802,500 | 0.31% | สัญญาขายล่วงหน้า |
| MILLENNIUM MANAGEMENT LLC | $672,345,116 | 1,617,653 | 0.28% | หุ้น |
| GOLDMAN SACHS GROUP INC | $636,389,783 | 1,531,145 | 0.26% | หุ้น |
| MARSHFIELD ASSOCIATES | $634,316,697 | 1,526,157 | 0.26% | หุ้น |
| UBS Group AG | $621,815,730 | 1,496,080 | 0.26% | หุ้น |
| RHUMBLINE ADVISERS | $607,608,189 | 1,461,895 | 0.25% | หุ้น |
| Ensign Peak Advisors, Inc | $599,888,338 | 1,443,323 | 0.25% | หุ้น |
| Qube Research & Technologies Ltd | $584,349,595 | 1,405,937 | 0.24% | หุ้น |
| Caisse de depot et placement du Quebec | $566,755,977 | 1,363,607 | 0.23% | หุ้น |
| AMERICAN CENTURY COMPANIES INC | $566,576,841 | 1,363,176 | 0.23% | หุ้น |
| Assenagon Asset Management S.A. | $542,834,808 | 1,306,053 | 0.22% | หุ้น |
| 1832 Asset Management L.P. | $537,572,517 | 1,293,392 | 0.22% | หุ้น |
| LPL Financial LLC | $531,650,741 | 1,279,144 | 0.22% | หุ้น |
| Davis Selected Advisers | $529,839,298 | 1,274,650 | 0.22% | หุ้น |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $528,071,215 | 1,270,532 | 0.22% | หุ้น |
| WOLVERINE TRADING, LLC | $512,799,408 | 1,485,600 | 0.21% | สัญญาขายล่วงหน้า |
| HSBC HOLDINGS PLC | $508,842,509 | 1,224,268 | 0.21% | หุ้น |
| FIL Ltd | $462,416,638 | 1,112,568 | 0.19% | หุ้น |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $461,418,710 | 1,110,167 | 0.19% | หุ้น |
| Ninety One UK Ltd | $458,593,637 | 1,103,370 | 0.19% | หุ้น |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $456,902,059 | 1,099,300 | 0.19% | สัญญาซื้อล่วงหน้า |
| Nuveen Asset Management, LLC | $449,500,757 | 888,587 | 0.18% | หุ้น |
| Veritas Asset Management LLP | $448,132,682 | 1,078,201 | 0.18% | หุ้น |
| NAYA CAPITAL MANAGEMENT UK LTD | $436,832,118 | 1,051,012 | 0.18% | หุ้น |
| NEUBERGER BERMAN GROUP LLC | $435,590,401 | 1,047,589 | 0.18% | หุ้น |
| MACKENZIE FINANCIAL CORP | $431,689,943 | 1,038,640 | 0.18% | หุ้น |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $430,280,958 | 1,035,250 | 0.18% | หุ้น |
| CTC LLC | $424,566,045 | 10,215 | 0.17% | สัญญาขายล่วงหน้า |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $411,538,954 | 990,157 | 0.17% | หุ้น |
| NEW YORK STATE COMMON RETIREMENT FUND | $408,705,604 | 983,340 | 0.17% | หุ้น |
| JANE STREET GROUP, LLC | $402,713,051 | 968,922 | 0.17% | หุ้น |
| CITADEL ADVISORS LLC | $400,319,438 | 963,163 | 0.16% | หุ้น |
| CTC LLC | $395,596,634 | 9,518 | 0.16% | สัญญาซื้อล่วงหน้า |
| Fayez Sarofim & Co | $394,573,729 | 949,339 | 0.16% | หุ้น |
| D. E. Shaw & Co., Inc. | $382,462,726 | 920,200 | 0.16% | สัญญาขายล่วงหน้า |
| GOLDMAN SACHS GROUP INC | $375,355,453 | 903,100 | 0.15% | สัญญาขายล่วงหน้า |
| MILLENNIUM MANAGEMENT LLC | $372,529,169 | 896,300 | 0.15% | สัญญาขายล่วงหน้า |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $366,901,369 | 1,355,931 | 0.15% | หุ้น |
| Allen Investment Management, LLC | $364,199,528 | 876,259 | 0.15% | หุ้น |
| FIRST MANHATTAN CO. LLC. | $360,530,629 | 867,432 | 0.15% | หุ้น |
| PRUDENTIAL FINANCIAL INC | $359,505,403 | 864,965 | 0.15% | หุ้น |
| Longview Partners (Guernsey) LTD | $350,167,028 | 842,497 | 0.14% | หุ้น |
| W1M Asset Management Ltd | $349,962,345 | 842,562 | 0.14% | หุ้น |
| AVIVA PLC | $347,327,444 | 835,665 | 0.14% | หุ้น |
| Point72 Asset Management, L.P. | $345,328,264 | 830,855 | 0.14% | หุ้น |
| TD Asset Management Inc | $337,496,548 | 812,012 | 0.14% | หุ้น |
| TORONTO DOMINION BANK | $337,017,326 | 810,859 | 0.14% | หุ้น |
| PineStone Asset Management Inc. | $335,630,369 | 807,522 | 0.14% | หุ้น |
| JENNISON ASSOCIATES LLC | $335,325,296 | 806,788 | 0.14% | หุ้น |
| PeakShares LLC | $329,595,000 | 793 | 0.14% | หุ้น |
| US BANCORP \DE\ | $328,365,156 | 790,042 | 0.13% | หุ้น |
| JONES FINANCIAL COMPANIES LLLP | $325,830,242 | 761,481 | 0.13% | หุ้น |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $320,418,726 | 770,923 | 0.13% | หุ้น |
| Clearbridge Investments, LLC | $312,811,372 | 752,620 | 0.13% | หุ้น |
| Robeco Institutional Asset Management B.V. | $311,375,867 | 749,166 | 0.13% | หุ้น |
ผู้บริหารบริษัท 64 รายชื่อผู้บริหาร · ผู้บริหาร 37 คน · กรรมการ 27 คน
| ผู้บริหารภายใน | บทบาท | กิจกรรมล่าสุด | หุ้นที่ถือครอง | ซื้อ 12 เดือน | ขาย 12 เดือน | สุทธิ 12 เดือน |
|---|---|---|---|---|---|---|
| Timothy John Noel | Chief Executive Officer, UHC | 23 มิถุนายน 2026 A | 17,651 | 0 | 0 | $0 |
| Stephen J Hemsley | CEO, UHG | 23 มิถุนายน 2026 A | 48,099 | 0 | 0 | $0 |
| Heather Cianfrocco | Chief Executive Officer, Optum | 18 มีนาคม 2025 A | 22,438 | 0 | 0 | $0 |
| Andrew Witty | CEO, UHG | 18 มีนาคม 2025 A | 112,162 | 0 | 0 | $0 |
| Brian R Thompson | CEO, UnitedHealthcare | 24 กันยายน 2024 A | 32,675 | 0 | 0 | $0 |
| David S Wichmann | Chief Executive Officer | 16 ธันวาคม 2020 F | 967,872 | 0 | 0 | $0 |
| Steven H Nelson | EVP & CEO, UnitedHealthcare | 25 มิถุนายน 2019 A | 38,502 | 0 | 0 | $0 |
| Larry C Renfro | Vice Chmn, UHG and CEO, Optum | 26 มิถุนายน 2018 A | 153,790 | 0 | 0 | $0 |
| Gail Boudreaux | EVP & CEO, UnitedHealthcare | 23 กันยายน 2014 A | 184,732 | 0 | 0 | $0 |
| George Lawrence Mikan III | EVP UHG & CEO, Optum | 5 มิถุนายน 2011 F | 209,279 | 0 | 0 | $0 |
| Tracy L Bahl | CEO, Uniprise | 7 พฤศจิกายน 2006 A | 4,230 | 0 | 0 | $0 |
| Robert J Sheehy | CEO, UnitedHealthcare | 7 พฤศจิกายน 2006 A | 3,009 | 0 | 0 | $0 |
| MCGUIRE WILLIAM W | Chief Executive Officer | 7 พฤศจิกายน 2006 A | 644,862 | 0 | 0 | $0 |
| Channing R Wheeler | CEO, Uniprise, Inc. | 28 พฤศจิกายน 2003 J | 8,356 | 0 | 0 | $0 |
| Wayne S Deveydt | Chief Financial Officer | 23 มิถุนายน 2026 A | 19,779 | 0 | 0 | $0 |
| John F Rex | President & CFO | 24 มิถุนายน 2025 A | 203,898 | 0 | 0 | $0 |
| Patrick J Erlandson | Chief Financial Officer | 2 พฤษภาคม 2006 A | 7,083 | 0 | 0 | $0 |
| Dirk C Mcmahon | President & COO, UHG | 19 มีนาคม 2024 A | 70,547 | 0 | 0 | $0 |
| Christopher R Zaetta | EVP & Chief Legal Officer | 23 มิถุนายน 2026 A | 15,860 | 0 | 0 | $0 |
| Erin Mcsweeney | EVP & Chief People Officer | 23 มิถุนายน 2026 A | 15,601 | 0 | 0 | $0 |
| Thomas E Roos | Chief Accounting Officer | 23 กุมภาพันธ์ 2026 A | 31,284 | 0 | 0 | $0 |
| Rupert M Bondy | EVP & Chief Legal Officer | 19 มีนาคม 2024 A | 9,607 | 0 | 0 | $0 |
| Marianne D Short | EVP & Chief Legal Officer | 25 กุมภาพันธ์ 2022 F | 138,315 | 0 | 0 | $0 |
| Patricia L Lewis | EVP and Chief HR Officer | 13 กุมภาพันธ์ 2022 F | 8,901 | 0 | 0 | $0 |
| Ellen D Wilson | Executive Vice President | 24 มีนาคม 2020 A | 58,387 | 0 | 0 | $0 |
| Eric S Rangen | Sr VP & Chief Acctg Officer | 24 มิถุนายน 2015 A | 11,577 | 0 | 0 | $0 |
| Lori Sweere | EVP, Human Capital | 10 พฤษภาคม 2013 S | 70,661 | 0 | 0 | $0 |
| Richard N Baer | EVP & Chief Legal Officer | 28 ธันวาคม 2012 F | 63,880 | 0 | 0 | $0 |
| Reed Vaughn Tuckson | EVP & Chief of Medical Affairs | 5 มิถุนายน 2012 F | 116,886 | 0 | 0 | $0 |
| William A Munsell | EVP, UnitedHealth Group | 5 มิถุนายน 2012 F | 268,167 | 0 | 0 | $0 |
| Anthony Welters | EVP, UnitedHealth Group | 5 มิถุนายน 2012 F | 119,909 | 0 | 0 | $0 |
| Christopher James Walsh | EVP and General Counsel | 24 พฤษภาคม 2011 A | 101,338 | 0 | 0 | $0 |
| Mitchell Eliot Zamoff | EVP and General Counsel | 24 พฤษภาคม 2011 A | 113,613 | 0 | 0 | $0 |
| Thomas L Strickland | EVP & Chief Legal Officer | 5 มิถุนายน 2008 A | 147,182 | 0 | 0 | $0 |
| Richard H Anderson | EVP, Pres, Commercial Svcs Grp | 28 พฤษภาคม 2007 A | 40,606 | 0 | 0 | $0 |
| Lois E Quam | EVP & Pres, Pub & Sr Mkt Grp | 28 พฤษภาคม 2007 A | 13,915 | 0 | 0 | $0 |
| Forrest Gregory Burke | Acting General Counsel | 17 เมษายน 2007 A | — | 0 | 0 | $0 |
| Frederick William Mcnabb III | กรรมการ | 1 กรกฎาคม 2026 A | 15,462 | 0 | 0 | $0 |
| Kristen Gil | กรรมการ | 1 กรกฎาคม 2026 A | 2,617 | 0 | 0 | $0 |
| Rice Valerie Montgomery MD | กรรมการ | 1 กรกฎาคม 2026 A | 7,876 | 0 | 0 | $0 |
| John H Noseworthy | กรรมการ | 1 กรกฎาคม 2026 A | 7,616 | 0 | 0 | $0 |
| Charles D. Baker | กรรมการ | 1 กรกฎาคม 2026 A | 2,396 | 0 | 1 | $-9,613 |
| Timothy Patrick Flynn | กรรมการ | 1 กรกฎาคม 2026 A | 10,875 | 0 | 0 | $0 |
| Scott Gottlieb | กรรมการ | 1 กรกฎาคม 2026 A | 659 | 0 | 0 | $0 |
| Paul R Garcia | กรรมการ | 1 กรกฎาคม 2026 A | 3,906 | 0 | 0 | $0 |
| Michele J Hooper | กรรมการ | 1 เมษายน 2026 A | 41,792 | 0 | 0 | $0 |
| BURKE RICHARD T | กรรมการ | 19 พฤษภาคม 2022 S | 1,215,000 | 0 | 0 | $0 |
| Gail R Wilensky | กรรมการ | 22 มีนาคม 2022 A | 24,590 | 0 | 0 | $0 |
| Glenn M Renwick | กรรมการ | 1 เมษายน 2021 A | 85,130 | 0 | 0 | $0 |
| BALLARD WILLIAM C JR | กรรมการ | 1 เมษายน 2020 A | 62,266 | 0 | 0 | $0 |
ผู้บริหารจากเอกสาร SEC Form 3/4/5; สุทธิ = เฉพาะการซื้อขายในตลาดเปิด
นักเคลื่อนไหวและเจ้าของ %+ 5 2 รายการ
นักลงทุนที่ยื่น SEC Schedule 13D — กรรมสิทธิ์ตามผลประโยชน์ที่แท้จริงสูงกว่า % 5 โดยมีเจตนาที่จะมีอิทธิพลต่อผู้ออกหลักทรัพย์ (การถือหุ้นของนักเคลื่อนไหว, การรณรงค์ในคณะกรรมการ, M&A) แต่ละแถวแสดงสถานะล่าสุดที่ทราบของตำแหน่งของผู้ยื่นคำร้องรายนั้น
| ผู้ยื่นคำร้อง | ยื่นแล้ว | ส่วนได้เสีย | สถานะ | วัตถุประสงค์ | การยื่นคำร้อง |
|---|---|---|---|---|---|
| UnitedHealth Group Incorporated ×3 เอกสารยื่นคำร้อง | 15 มกราคม 2021 | — | การยื่นคำร้องครั้งแรก | — | SEC |
| Ingenix, Inc., UnitedHealth Group Incorporated | 5 มิถุนายน 2006 | — | การยื่นคำร้องครั้งแรก | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
การถือครอง ETF ถือโดย ETF 268 ราย
น้ำหนักสะท้อนถึงการถือครองหุ้นโดยตรง (N-PORT) เท่านั้น กองทุนเลเวอเรจหรือกองทุนที่อิงตราสารอนุพันธ์อาจมีการเปิดรับความเสี่ยงจากสัญญาแลกเปลี่ยน (swap) เพิ่มเติมซึ่งไม่แสดง
| กองทุน | น้ำหนัก | หน่วย | ณ วันที่ | แหล่งที่มา |
|---|---|---|---|---|
| IHF · iShares Trust | 21.13% | 647,431 SH | 8 สิงหาคม 2026 | รายวัน |
| DJD · Invesco Exchange-Traded Fund Trust | 8.15% | 99,571 SH | 8 สิงหาคม 2026 | รายวัน |
| IYH · iShares Trust | 5.93% | 540,690 SH | 8 สิงหาคม 2026 | รายวัน |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 5.83% | 1,751 NS | 30 เมษายน 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 5.56% | 2,728,542 SH | 8 สิงหาคม 2026 | รายวัน |
| FHLC · FIDELITY COVINGTON TRUST | 5.42% | 417,583 NS | 30 เมษายน 2026 | N-PORT |
| HRTS · Tema ETF Trust | 5.24% | 7,159 NS | 31 พฤษภาคม 2026 | N-PORT |
| FLAG · Global X Funds | 5.12% | 228 NS | 30 เมษายน 2026 | N-PORT |
| SCHD · SCHWAB STRATEGIC TRUST | 5.09% | 12,713,822 NS | 31 พฤษภาคม 2026 | N-PORT |
| RXL · ProShares Trust | 4.98% | 9,446 NS | 31 พฤษภาคม 2026 | N-PORT |
| DOGG · First Trust Exchange-Traded Fund IV | 4.95% | 8,762 NS | 30 เมษายน 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 4.84% | 18,062 NS | 30 เมษายน 2026 | N-PORT |
| DJIA · Global X Funds | 4.63% | 21,113 NS | 30 เมษายน 2026 | N-PORT |
| DYLG · Global X Funds | 4.61% | 732 NS | 30 เมษายน 2026 | N-PORT |
| VEGN · ETF Series Solutions | 4.22% | 17,678 NS | 30 เมษายน 2026 | N-PORT |
| IXJ · iShares Trust | 4.16% | 428,283 SH | 8 สิงหาคม 2026 | รายวัน |
| GFGF · EA Series Trust | 3.98% | 3,881 NS | 29 พฤษภาคม 2026 | N-PORT |
| EQIN · Columbia ETF Trust I | 3.65% | 27,252 NS | 30 เมษายน 2026 | N-PORT |
| LGRO · ALPS ETF Trust | 3.45% | 12,238 NS | 31 พฤษภาคม 2026 | N-PORT |
| JXX · Janus Detroit Street Trust | 3.34% | 3,270 NS | 30 เมษายน 2026 | N-PORT |
| PWV · Invesco Exchange-Traded Fund Trust | 3.34% | 146,788 SH | 8 สิงหาคม 2026 | รายวัน |
| DDM · ProShares Trust | 3.30% | 45,359 NS | 31 พฤษภาคม 2026 | N-PORT |
| PRVS · Parnassus Funds II | 3.25% | 1,978 NS | 30 มิถุนายน 2026 | N-PORT |
| BKDV · BNY Mellon ETF Trust II | 3.14% | 117,081 NS | 30 เมษายน 2026 | N-PORT |
| QLTY · GMO ETF Trust | 2.85% | 337,119 NS | 31 พฤษภาคม 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 2.72% | 735 NS | 31 พฤษภาคม 2026 | N-PORT |
| FMCX · Northern Lights Fund Trust IV | 2.67% | 8,276 NS | 31 พฤษภาคม 2026 | N-PORT |
| FMCE · Northern Lights Fund Trust IV | 2.67% | 4,741 NS | 31 พฤษภาคม 2026 | N-PORT |
| CBLS · Elevation Series Trust | 2.65% | 3,800 NS | 30 เมษายน 2026 | N-PORT |
| UDOW · ProShares Trust | 2.52% | 55,671 NS | 31 พฤษภาคม 2026 | N-PORT |
| TBG · EA Series Trust | 2.51% | 15,609 NS | 30 เมษายน 2026 | N-PORT |
| ESN · Northern Lights Fund Trust II | 2.47% | 18,098 NS | 31 พฤษภาคม 2026 | N-PORT |
| OMAH · Tidal Trust III | 2.46% | 49,724 NS | 30 เมษายน 2026 | N-PORT |
| SNPV · DBX ETF Trust | 2.35% | 14,245 NS | 29 พฤษภาคม 2026 | N-PORT |
| PALC · Pacer Funds Trust | 2.35% | 14,601 NS | 30 เมษายน 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 2.25% | 2,424 NS | 31 พฤษภาคม 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 2.20% | 536,993 SH | 8 สิงหาคม 2026 | รายวัน |
| SFYF · Tidal Trust I | 2.08% | 2,389 NS | 31 พฤษภาคม 2026 | N-PORT |
| FLV · AMERICAN CENTURY ETF TRUST | 2.07% | 19,236 NS | 31 พฤษภาคม 2026 | N-PORT |
| HGRO · ETF Opportunities Trust | 2.06% | 5,413 NS | 30 เมษายน 2026 | N-PORT |
| CGDV · Capital Group Dividend Value ETF | 2.02% | 1,872,479 NS | 31 พฤษภาคม 2026 | N-PORT |
| GMOV · GMO ETF Trust | 2.02% | 4,839 NS | 31 พฤษภาคม 2026 | N-PORT |
| GKAT · Advisors Series Trust | 1.99% | 10,970 NS | 31 มีนาคม 2026 | N-PORT |
| DUSA · Davis Fundamental ETF Trust | 1.96% | 61,270 NS | 30 เมษายน 2026 | N-PORT |
| GVIP · Goldman Sachs ETF Trust | 1.84% | 27,590 NS | 31 พฤษภาคม 2026 | N-PORT |
| MGV · VANGUARD WORLD FUND | 1.78% | 570,801 SH | 8 สิงหาคม 2026 | รายวัน |
| MEDI · Harbor ETF Trust | 1.77% | 1,315 NS | 30 เมษายน 2026 | N-PORT |
| KAT · Advisors Series Trust | 1.75% | 43,653 NS | 31 มีนาคม 2026 | N-PORT |
| DGRO · iShares Trust | 1.69% | 1,819,359 SH | 8 สิงหาคม 2026 | รายวัน |
| VIG · VANGUARD SPECIALIZED FUNDS | 1.65% | 5,130,541 SH | 8 สิงหาคม 2026 | รายวัน |